Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

HUTCHMED (China) Limited

HCMNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$15.09
$-0.20(-1.31%)
U.S. Market opens in 13h 56m

HUTCHMED (China) Limited (HCM) Stock Overview

Explore HUTCHMED (China) Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.7B
P/E Ratio5.68
EPS (TTM)$2.65
ROE0.47%
Fundamental Analysis

AI Price Forecasts

1 Month$14.23
3 Months$15.05
1 Year Target$17.74

HCM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HUTCHMED (China) Limited (HCM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $17.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.68 and a market capitalization of 2.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.78%
5-Day Change
1.81%
1-Month Change
-0.91%
3-Month Change
8.36%
6-Month Change
-5.83%
Year-to-Date (YTD) Change
11.14%
1-Year Change
-1.49%
3-Year Change
-3.74%
5-Year Change
-50.20%
All-Time (Max) Change
12.37%

Contact Information

852 2128 1188
Cheung Kong Center, Hong Kong, NaN, NaN

Company Facts

18,110 Employees
IPO DateMar 16, 2016
CountryHK
Actively Trading

Frequently Asked Questions